Dupilumab Induces Long-Term On-Treatment Clinical Remission in Patients With Type 2 Asthma

BACKGROUND: Remission is proposed as a multicomponent outcome for patients with severe asthma. OBJECTIVE: This post hoc analysis of QUEST (NCT02414854) and TRAVERSE (NCT02134028) evaluated whether dupilumab treatment leads to clinical asthma remission (

• Pavord, I. D.
• Rabe, K. F.
• Israel, E.
• Szefler, S. J.
• Brusselle, G.
• Pandit-Abid, N.
• Altincatal, A.
• Chen, Z.
• Amin, N.
• Khan, A. H.
• Lederer, D. J.
• Zhang, Y.
• Rowe, P. J.
• Deniz, Y.
• Radwan, A.
• Jacob-Nara, J. A.
• Busse, W. W.